期刊文献+

NK细胞杀伤ARH-77细胞的活性及机制的初步探讨

Cytotoxicity of allogenic NK cells against myeloma cells in vitro and its mechanism
下载PDF
导出
摘要 目的探讨同种异体NK细胞杀伤人骨髓瘤ARH-77细胞的活性及机制。方法 LDH释放法检测NK细胞杀伤ARH-77细胞的活性;RT-PCR方法和流式细胞仪分别检测K562和ARH-77细胞NKG2D配体和HLA-I基因和分子。阻断K562和ARH-77细胞NKG2D配体,观察NK细胞杀伤活性的变化。结果相同效靶比时NK细胞杀伤ARH-77细胞的活性明显低于杀伤K562细胞。两种细胞均表达MICA/B和ULBP1~3基因。K562细胞高表达MICA/B和ULBP1~3分子,不表达HLA-Ⅰ类分子;ARH-77细胞低表达ULBP1~3分子,高表达HLA-Ⅰ类分子。ARH-77细胞HLA基因型为A2、3,B15、35,Cw3、4。阻断NKG2D配体,NK细胞对K562细胞的杀伤活性明显降低,对ARH-77细胞的杀伤活性无明显改变;阻断HLA-Ⅰ类分子后,NK细胞对K562细胞的杀伤活性无变化,对ARH-77细胞的杀伤活性明显提高。结论 ARH-77细胞对NK细胞的杀伤敏感性低,其机制与其高表达HLA-Ⅰ类分子、低表达NKG2D配体有关。 Objective To observe the cytotoxicity of allogenic natural killer(NK) cells against myeloma cells in vitro and preliminarily explore its molecular mechanism.Methods Cytotoxicity of NK cells against ARH-77 cells was analyzed by LDH releasing assay at different effector-to-target cell ratios(E:T).The genes and proteins of NKG2D ligands on K562 and ARH-77 cell surface were measured by RT-PCR and flow cytometry,respectively.The genes of HLA-I molecules in ARH-77 cell and KIR of NK cells were assayed by PCR-SSCP.In blocking experiments,monoclonal antibodies of HLA-I molecule and NKG2D ligands were added to the target cell at E∶T of 20∶1.Results Compared with K562 cells,ARH-77 cells resisted NK cell cytolysis.The mRNA genes of MICA/B and ULBP1-3 were positive in two cell lines.K562 cell lines highly expressed MICA/B and ULBP1-3 protein but weakly expressed HLA-I molecule,while ARH-77 cell lines did the opposite.The HLA-I genotypes of ARH-77 cells were A2,3;B15,35;Cw3,4.NKG2D ligands blocking experiments revealed that the cytotoxicity of NK cells against K562 cell was partially inhibited,but that against ARH-77 cell was not affected.Conversely,the cytotoxicity of NK cells against ARH-77 cell was obviously improved,and that against K562 cell was not affected when HLA-I molecules were shaded.Conclusion Weak expression of NKG2D ligands and high expression HLA-I molecules by NK cells may contribute to the reduced cytotoxicity of NK cells against myeloma cell ARH-77.
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2011年第1期97-101,共5页 Journal of Xi’an Jiaotong University(Medical Sciences)
关键词 自然杀伤细胞 自然杀伤细胞受体 骨髓瘤 HLA-Ⅰ类分子 natural killer(NK) cell NK cell receptor myeloma HLA-I molecule
  • 相关文献

参考文献12

  • 1FIONDA C, SORIANI A, MALGARINI G, et al. Heat shock protein-90 inhibitors increase MHC class 1-related chain A and B ligand expression on multiple myeloma ceils and their ability to trigger NKcell degranulation [J]. J Immunol, 2009, 183(7): 4385-4394.
  • 2周健,牛新清,梅家转,王杨,涂三芳,何颖芝,周雪云,郭坤元.同种异体NK细胞对不同肿瘤细胞的体外杀伤活性及其机制的初步探讨[J].现代免疫学,2008,28(1):7-11. 被引量:5
  • 3FRIESE MA, PLATTEN M, LUTZ SZ, et al. MICA/NKG2D- mediated immunogene therapy of experimental gliomas[J]. Cancer Res, 2003, 63(24):8996-9006.
  • 4LODOEN MB, LANIERT LL. Natural killer cells as an initial defense against pathogens [J].Curt Opin Immunol, 2006, 18: 391-398.
  • 5VILCHES C, PARHAM P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity [J]. Annu Rev Immunol, 2002, 20(1):217-251.
  • 6HSU KC, KEEVER-TAYLOR CA, WILTON A, et al. Improved outcome in HLA-identical sibling hematopoietic stemcell transplantation for acute myelogenous leukemia predicted by KIR and FILA genotypes[J].Blood, 2005, 105(12):4878- 4884.
  • 7GASSER S, RAULET DH. Activation and self-tolerance of natural killer ceils [J]. Immunol, 2006, 214(1):130-142.
  • 8BRYCESON YT, MARCH ME, LJUNGGREN H, et al. Activation, coactivation, and eostimulation of resting human natural cells[J]. Immunol Rev, 2006, 214(1):73-91.
  • 9CARBONE E, NERI P, MESURACA M, et al. HLA class I NKG2D and natural cytotoxicity receptors regulate multiple my eloma cell recognition by natural killer cells [J]. Blood, 2005 105(1)251-258.
  • 10VON STRANDMANN EE, HANSEN HP, REINERS KS, et al. A novel bispecific protein (ULBP2- BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivo [J].Blood, 2006, 107 (5) : 1955-1962.

二级参考文献8

  • 1[1]Wu J,Song Y,Bakker AB,et al.An activating immunoreceptor complex formed by NKG2D and DAP10[J].Science,1999,285 (5428):730-732.
  • 2[2]Stephens HA.MICA and MICB gene:Can the enigma of their polymorphism be resolved[J].Trends Immunol,2001,22(7):378-385.
  • 3[3]Friese MA,Platten M,Lutz SZ,et al.MICA/NKG2D-mediated immunogene therapy of experimental gliomas[J].Cancer Res,2003,63(24):8996-9006.
  • 4[4]Gasser S,Raulet DH.Activation and self-tolerance of natural killer cells[J].Immunology,2006,214(1):130-142.
  • 5[6]Carbone E,Neri P,Mesuraca M,et al.HLA class Ⅰ,NKG2D and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells[J].Blood,2005,105(1):251-258.
  • 6[8]Raulet DH.Missing self recognition and self tolerance of natural killer (NK) cells[J].Semin Immunol,2006,18(3):145-150.
  • 7龚卫娟,杨珏琴,姚芳娟,许玲娣,范丽安.K562细胞转染HLA-B分子对NK细胞杀伤功能的影响[J].上海免疫学杂志,2003,23(4):228-231. 被引量:5
  • 8池永斌,范丽安.激活性受体NKG2D研究进展[J].现代免疫学,2004,24(2):169-171. 被引量:4

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部